A visual nomogram for predicting the risk of transient severe motion artifacts on Gd-EOB-DTPA-enhanced MRI in high-risk hepatocellular carcinoma patients: a multicenter study
摘要
To investigate the incidence and identify risk factors for transient severe motion (TSM) during the arterial phase of gadoxetate disodium (Gd-EOB-DTPA)-enhanced MRI in hepatocellular carcinoma (HCC) high-risk patients.
MethodsThis multicenter study enrolled 214 high-risk HCC patients. Two radiologists independently evaluated image quality per phase with a 5-point scale. We defined TSM as the concurrent presence of severe (grade 4–5) motion artifacts on arterial phase images and minimal (grade 1–2) artifacts on all subsequent phases. To identify independent predictors, we performed logistic regression analysis and constructed a clinical nomogram for risk stratification.
ResultsThe incidence of TSM during arterial phase was 16.4% (35/214), with severe motion artifacts (grade 4 or 5) being the most common (17.8%, 38/214). Multivariate analysis identified four factors independently associated with TSM: old age (≥ 60 years), high BMI (≥ 25 kg/m2), chronic obstructive pulmonary disease (COPD), and severe pleural effusion (all p < 0.05), with pleural effusion exhibiting the strongest effect (OR 5.33). A nomogram integrating these factors showed a TSM probability of 84.6% when all were present.
ConclusionOld age, high BMI, COPD, and severe pleural effusion are independent risk factors for TSM of Gd-EOB-DTPA-enhanced MRI in high-risk HCC patients.